Pharmacy Times®
Specialty Pharmacy Times
  • Hepatitis C on Track to Become a Rare Disease by 2036
  • FDA Accepts First Application in US for Biosimilar
  • The Updated HIV Prevention Guidelines
  • Study Supports Mammography in Women 75 Years and Older
  • Limited Market for Ebola Vaccine Hinders Development
  • Affordable Care Act Projected to Drive Up Prescription Drug Spending in Coming Years
Relief Group Calls Ebola Response Inadequate While American Patients Get Tested for Possible Exposure
Davy James, Associate Editor
Doctors Without Borders said virus cannot be contained without massive mobilization of resources to West Africa.
FDA Approves New Treatment for Rare Genetic Disease
Davy James, Associate Editor
Genzyme’s eliglustat offers long-term treatment for Type 1 Gaucher disease.
Bass, Berry & Sims Establishes Specialty Pharmacy, Pharma Services and Distribution Services Practice
Former chief counsel and VP of strategic development, and assistant general counsel for Fortune 500 health care provider, to lead new practice area.
Zydelig by Gilead Sciences, Inc
Michael R. Page, PharmD, RPh
The FDA has approved Zydelig (idelalisib) tablets for the later-line treatment of 3 types of cancer, including chronic lymphocytic leukemia, follicular B-cell non-Hodgkin lymphoma, and small lymphocytic lymphoma.
Entyvio by Takeda Pharmaceuticals America, Inc
Michael R. Page, PharmD, RPh
The FDA has approved Entyvio (vedolizumab), an integrin-receptor antagonist for treatment of ulcerative colitis and Crohn’s disease in adult patients.
Featured Video
Improving Medication Adherence Through Technology
Thomas Morrow, MD, chief medical officer at Next IT, discusses how virtual health assistants are changing how specialty pharmacies can interact with patients to improve adherence.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 5
Number: 3
Conference Calendar
â—„        August 2014        â–º
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.